IVRI is an acronym that stands for the International Vaccine Institute. The International Vaccine Institute is an independent, non-profit organization established in 1997, with its headquarters in Seoul, South Korea. It is dedicated to accelerating the development and introduction of new and improved vaccines to protect people, especially those in low and middle-income countries, against deadly infectious diseases. IVRI carries out research, development, and training programs with a focus on diseases that primarily affect the developing world, such as cholera, typhoid fever, and hepatitis.
The organization plays a crucial role in vaccine development by collaborating with various partners, including governments, academic institutions, and pharmaceutical companies. Through its research efforts, IVRI contributes to the advancement of knowledge and understanding of diseases, immunology, and vaccine technologies. It also utilizes this knowledge to provide training and capacity-building programs for scientists and health professionals from resource-limited settings.
IVRI's ultimate goal is to ensure equitable access to life-saving vaccines, particularly for the most vulnerable populations. By promoting research, technology transfer, and local production, IVRI aims to enable countries to develop their own sustainable vaccine production capacity, reducing their dependence on external sources.
In summary, IVRI is an international organization dedicated to the research, development, and introduction of vaccines, with a particular focus on addressing the needs of low and middle-income countries. Its efforts aim to save lives, improve public health, and contribute to the eradication of deadly infectious diseases worldwide.
